“…Recent studies have shown that besides their quantity, the qualities of fatty acids (e.g., saturated fatty acid toxicity and omega-3/omega-6 fatty acid balance) are involved in various human diseases, including metabolic syndrome, inflammatory diseases, and neuronal diseases ( Bazinet and Laye, 2014 ; Estadella et al., 2013 ). Especially, omega-3 polyunsaturated fatty acids (PUFAs), such as docosahexaenoic acid (DHA), and omega-6 PUFAs, including arachidonic acid (ARA), are implicated in diverse cellular processes and in the progression of these diseases as bioactive lipid mediators, or as components of membrane phospholipids (PLs) ( Harayama and Shimizu, 2020 ; Jump et al., 2013 ; Milligan et al., 2017 ; Shimizu, 2009 ; Wang and Tontonoz, 2019 ). PUFA-containing PLs are supposed to affect the membrane-based cellular processes, such as endo/exocytosis, and localization and functions of a number of membrane proteins by providing fluidity to the cellular membrane ( Antonny et al., 2015 ; Harayama and Riezman, 2018 ).…”